ArticleJournal of thoracic disease2019

A retrospective study of low-dose apatinib combined with S-1 in patients with advanced non-small cell lung cancer.

Tong Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.